Hwa Young Lee1, Jin Woo Kim1, Sang Haak Lee1, Hyoung Kyu Yoon1, Jae Jeong Shim1, Jeong-Woong Park1, Jae-Hyung Lee1, Kwang Ha Yoo1, Ki-Suck Jung1, Chin Kook Rhee1. 1. 1 Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea ; 2 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Republic of Korea ; 3 Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, St. Paul's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea ; 4 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea ; 5 Department of Pulmonary, Allergy and Critical Care Medicine, Korea University Guro Hospital, Seoul, Republic of Korea ; 6 Department of Pulmonary and Critical Care Medicine, Gachon University, Gil Medical Center, Incheon, Korea ; 7 Department of Internal Medicine, Eulji University College of Medicine, Seoul, Republic of Korea ; 8 Division of Pulmonary, Allergy and Critical Care Medicine Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Republic of Korea ; 9 Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Medical Center, Hallym University College of Medicine, Anyang, Republic of Korea.
Abstract
BACKGROUND: This study was designed to evaluate the effect of chronic bronchitis (CB) symptoms and degree of emphysema in a multicenter Korean cohort. METHODS: From April 2012 to May 2015, patients diagnosed with chronic obstructive lung disease (COPD) who were aged above 40 years at 46 hospitals throughout Korea were enrolled. All of the patients were classified according to CB symptoms and the diffusing capacity of the lung for carbon monoxide (DLCO); demographic data, symptom scores, and the result of lung function tests and exacerbations were then analyzed. RESULTS: A total of 812 patients were enrolled. Among these patients, 285 (35.1%) had CB symptoms. A total of 51% of patients had high DLCO without CB symptoms [CB (-) high DLCO], 24.9% had CB symptoms only [CB (+) high DLCO], 14.2% had low DLCO only [CB (-) low DLCO], and 10.2% had both low DLCO and CB [CB (+) low DLCO]. Patients with CB (+) low DLCO showed a significantly lower post-bronchodilator (BD) forced expiratory volume for 1 second (FEV1) and more severe dyspnea than patients with CB (-) high DLCO. On multivariate analysis, the risk of acute exacerbation was two times higher [odds ratio (OR) 2.06; 95% confidence interval (CI): 1.18-3.62; P=0.01] in the CB (+) low DLCO group than in the CB (-) high DLCO group. CONCLUSIONS: In this COPD cohort, patients showed distinct clinical characteristics and outcomes according to the presence of CB and degree of DLCO. CB and low DLCO were associated with the risk of acute exacerbation.
BACKGROUND: This study was designed to evaluate the effect of chronic bronchitis (CB) symptoms and degree of emphysema in a multicenter Korean cohort. METHODS: From April 2012 to May 2015, patients diagnosed with chronic obstructive lung disease (COPD) who were aged above 40 years at 46 hospitals throughout Korea were enrolled. All of the patients were classified according to CB symptoms and the diffusing capacity of the lung for carbon monoxide (DLCO); demographic data, symptom scores, and the result of lung function tests and exacerbations were then analyzed. RESULTS: A total of 812 patients were enrolled. Among these patients, 285 (35.1%) had CB symptoms. A total of 51% of patients had high DLCO without CB symptoms [CB (-) high DLCO], 24.9% had CB symptoms only [CB (+) high DLCO], 14.2% had low DLCO only [CB (-) low DLCO], and 10.2% had both low DLCO and CB [CB (+) low DLCO]. Patients with CB (+) low DLCO showed a significantly lower post-bronchodilator (BD) forced expiratory volume for 1 second (FEV1) and more severe dyspnea than patients with CB (-) high DLCO. On multivariate analysis, the risk of acute exacerbation was two times higher [odds ratio (OR) 2.06; 95% confidence interval (CI): 1.18-3.62; P=0.01] in the CB (+) low DLCO group than in the CB (-) high DLCO group. CONCLUSIONS: In this COPD cohort, patients showed distinct clinical characteristics and outcomes according to the presence of CB and degree of DLCO. CB and low DLCO were associated with the risk of acute exacerbation.
Authors: Maria Montes de Oca; Ronald J Halbert; Maria Victorina Lopez; Rogelio Perez-Padilla; Carlos Tálamo; Dolores Moreno; Adrianna Muiño; José Roberto B Jardim; Gonzalo Valdivia; Julio Pertuzé; Ana Maria B Menezes Journal: Eur Respir J Date: 2012-01-26 Impact factor: 16.671
Authors: Jessica Bon; Carl R Fuhrman; Joel L Weissfeld; Steven R Duncan; Robert A Branch; Chung-Chou H Chang; Yingze Zhang; Joseph K Leader; David Gur; Susan L Greenspan; Frank C Sciurba Journal: Am J Respir Crit Care Med Date: 2010-10-08 Impact factor: 21.405
Authors: Alejandro A Díaz; Victor Pinto-Plata; Camila Hernández; Javier Peña; Cristóbal Ramos; Juan C Díaz; Julieta Klaassen; Cecilia M Patino; Fernando Saldías; Orlando Díaz Journal: Respir Med Date: 2015-04-23 Impact factor: 3.415
Authors: Jørgen Vestbo; Lisa D Edwards; Paul D Scanlon; Julie C Yates; Alvar Agusti; Per Bakke; Peter M A Calverley; Bartolome Celli; Harvey O Coxson; Courtney Crim; David A Lomas; William MacNee; Bruce E Miller; Edwin K Silverman; Ruth Tal-Singer; Emiel Wouters; Stephen I Rennard Journal: N Engl J Med Date: 2011-09-26 Impact factor: 91.245
Authors: Meilan K Han; Ella A Kazerooni; David A Lynch; Lyrica X Liu; Susan Murray; Jeffrey L Curtis; Gerard J Criner; Victor Kim; Russell P Bowler; Nicola A Hanania; Antonio R Anzueto; Barry J Make; John E Hokanson; James D Crapo; Edwin K Silverman; Fernando J Martinez; George R Washko Journal: Radiology Date: 2011-07-25 Impact factor: 11.105
Authors: Victor Kim; Adam Davey; Alejandro P Comellas; Meilan K Han; George Washko; Carlos H Martinez; David Lynch; Jin Hwa Lee; Edwin K Silverman; James D Crapo; Barry J Make; Gerard J Criner Journal: Respir Res Date: 2014-04-27
Authors: Aparna Balasubramanian; Neil R MacIntyre; Robert J Henderson; Robert L Jensen; Gregory Kinney; William W Stringer; Craig P Hersh; Russell P Bowler; Richard Casaburi; MeiLan K Han; Janos Porszasz; R Graham Barr; Barry J Make; Robert A Wise; Meredith C McCormack Journal: Chest Date: 2019-07-25 Impact factor: 9.410
Authors: Sei Won Kim; Chin Kook Rhee; Ki Uk Kim; Sang Haak Lee; Hun Gyu Hwang; Yu Il Kim; Deog Kyeom Kim; Sang Do Lee; Yeon-Mok Oh; Hyoung Kyu Yoon Journal: Int J Chron Obstruct Pulmon Dis Date: 2017-01-21